UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Only 1% of severe epilepsy patients get surgery in Korea
Most Korean patients with severe epilepsy -- except for 1.3 percent of them...
by Song Soo-youn
|
2019-08-09 13:48
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
AstraZeneca and MSD announced positive results from their phase 3 PROfound ...
by Lee Han-soo
|
2019-08-08 16:48
라인
Mammotome procedure recognized as new medical technology
The health authorities have finally acknowledged ultrasound-guided vacuum-a...
by Choi Gwang-seok
|
2019-08-08 16:02
라인
SNUH resumes operation of UAE hospital
Seoul National University Hospital (SNUH) said that it launched the second-...
by Lee Han-soo
|
2019-08-08 15:59
라인
Drug regulator to enhance clinical trial management by 2023
The Ministry of Food and Drug Safety on Thursday announced a “Comprehensive...
by Lee Hye-seon
|
2019-08-08 14:55
라인
Preoperative embolization proves effective against non-hypervascular metastatic spine tumors
Researchers at St.Mary’s Seoul Hospital have concluded preoperative emboliz...
by Lee Han-soo
|
2019-08-08 14:54
라인
‘CPhI Korea thriving on local firms’ zeal for drug export’
Korea Pharmaceutical Traders Association (KPTA) said it would open a large-...
by Jeong Sae-im
|
2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
Athenex, Hanmi’s U.S. partner, presented the topline data showing that Orax...
by Lee Han-soo
|
2019-08-08 14:53
라인
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
Daewoong Pharmaceutical's launch of Jeuveau, its botulinum toxin (BTX) ...
by Lee Han-soo
|
2019-08-07 16:22
라인
Lilly’s anticancer combo drug nears getting insurance benefit
Eli Lilly said its anticancer drug Verzenio showed an improvement in overal...
by Kim Yun-mi
|
2019-08-07 15:44
라인
Over 5,700 patients received Allergan’s breast implants linked to rare cancer
Health authorities around the world recently recalled Allergan’s breast imp...
by Song Soo-youn
|
2019-08-07 15:43
라인
[Reporter’s Notebook] SillaJen should be ashamed of itself
It was an obvious failure of a drug trial, but the drugmaker said it was no...
by Jeong Sae-im
|
2019-08-07 13:59
라인
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo
|
2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo
|
2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo
|
2019-08-06 17:20
라인
Myongji Hospital opens sports medicine center
Myongji Hospital said that it has opened a new sports medicine center at th...
by Lee Han-soo
|
2019-08-06 16:54
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi
|
2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo
|
2019-08-06 15:43
라인
HLB to seek pre-NDA meeting with FDA for rivoceranib
HLB said it would request for a pre-New Drug Application (NDA) meeting with...
by Jeong Sae-im
|
2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo
|
2019-08-06 13:50
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top